School of Medicine

The issue of ever-changing health care, particularly drug discovery, care delivery and introducing new technologies, will be the topic of a morning-long symposium Jan. 23 at Washington University in St. Louis’ Olin Business School as part of the David R. Calhoun Lectureship.

In a new study from the School of Medicine, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders.

Gerald Medoff, MD, professor emeritus of medicine and beloved former director of the Division of Infectious Diseases at the School of Medicine, died peacefully Jan. 14, 2019, in hospice care in Creve Coeur, Mo., following a long bout with Parkinson’s disease. He was 82.

Scientists at Washington University in St. Louis plan to use a new imaging technique to get a better look at breast tumors and reduce unnecessary biopsies.

In studying a bacterium that causes disease in hospitalized people, researchers at the School of Medicine have figured out a key step in the transmission of antibiotic resistance from one bacterium to another. Their insight suggests a new strategy for stopping the spread of antibiotic resistance.

A new study from the School of Medicine has found that decreased deep sleep is associated with early signs of Alzheimer’s disease.

The School of Medicine has received a $9 million grant from the National Institutes of Health (NIH) to study the life histories of breast and pancreatic cancers. The grant is part of the NIH’s Human Tumor Atlas Network, a large-scale effort to better understand tumors.

Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, and Yoram Rudy, of the School of Engineering & Applied Science, and have been selected as National Academy of Inventors fellows. They will be inducted in April at a ceremony during the academy’s annual meeting in Houston.

Researchers at the School of Medicine — working with mice with sleep problems similar to those experienced by people with the genetic disease neurofibromatosis type 1 (NF1) — believe the animals will help shed light on insomnia linked to NF1 or other factors.

A new study at the School of Medicine finds disparities between African-Americans and Caucasians in a key biomarker for Alzheimer’s disease — suggesting that tools to diagnose the disease in Caucasian populations may not work as well in African-Americans.